Who We Are
340B Health represents public and private nonprofit hospitals and health systems that participate in the 340B drug discount program.Learn more about us
Meet Mikayla, Our Newest Patient Face of 340BClick here to watch
Visit The Exchange today to connect with over 9,000 of your 340B colleagues on the topics that matter most.Click here to post
October 15, 2019— The manufacturers of seven widely used drugs raised their prices with no clinical evidence to support those increases, according to a new study by the Institute for Clinical and Economic Review (ICER), an independent research organization. These price hikes added $5.1...